Skip to Main Content

Author Details

Elias Campo
Institute for Biomedical Research August Pi I Sunyer
1981
757
121
PMIDPaper TitleJournal TitlePublished Year
37881141Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab.Br J Haematol2024
37560801<i>BCL3</i> rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases.Haematologica2024
38017105Chronic lymphocytic leukemia patient-derived xenografts recapitulate clonal evolution to Richter transformation.Leukemia2024
38055913Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes.J Clin Oncol2024
37994105Massive parallel sequencing unveils homologous recombination deficiency in follicular dendritic cell sarcoma.Haematologica2024
37942762A low total metabolic tumor volume independently predicts for a longer time to first treatment in initially observed, low tumor burden follicular lymphoma.Hematol Oncol2024
36221796Intravascular Large B-Cell Lymphoma Genomic Profile Is Characterized by Alterations in Genes Regulating NF-κB and Immune Checkpoints.Am J Surg Pathol2023
37803049MALAT1 expression is associated with aggressive behavior in indolent B-cell neoplasms.Sci Rep2023
37957421The 2022 classifications of lymphoid neoplasms : Keynote.Pathologie (Heidelb)2023
37485564Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 2 study from GELTAMO.Br J Haematol2023
37746159All-CLL: A Capture-based Next-generation Sequencing Panel for the Molecular Characterization of Chronic Lymphocytic Leukemia.Hemasphere2023
37947807[Molecular diagnostics for vitreoretinal lymphoma].Pathologie (Heidelb)2023
37505099IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia.Blood Adv2023
37974680Laryngeal EBV-positive Inflammatory Follicular Dendritic cell/fibroblastic Reticular cell Tumour.Indian J Otolaryngol Head Neck Surg2023
37053555Decoding the molecular heterogeneity of pediatric monomorphic post-solid organ transplant lymphoproliferative disorders.Blood2023
36989492Chromatin activation profiling of stereotyped chronic lymphocytic leukemias reveals a subset 8-specific signature.Blood2023
36975733Mutational Profile and Pathological Features of a Case of Interleukin-10 and RGS1-Positive Spindle Cell Variant Diffuse Large B-Cell Lymphoma.Hematol Rep2023
37304935Robust CRISPR-Cas9 Genetic Editing of Primary Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma Cells.Hemasphere2023
37031299A novel patient-derived 3D model recapitulates mantle cell lymphoma lymph node signaling, immune profile and in vivo ibrutinib responses.Leukemia2023
37260508RFcaller: a machine learning approach combined with read-level features to detect somatic mutations.NAR Genom Bioinform2023
36995085Unraveling the genetics of transformed splenic marginal zone lymphoma.Blood Adv2023
36994552Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors.Hematol Oncol2023
36586001Advances in the Classification of Myeloid and Lymphoid Neoplasms.Virchows Arch2023
36849712Lack of reproducibility of histopathological features in MYC-rearranged large B cell lymphoma using digital whole slide images: a study from the Lunenburg lymphoma biomarker consortium.Histopathology2023
36716220Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/DSHNHL analysis.Blood Adv2023
36509891Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma.Leukemia2023
36459219Diffuse large B-cell lymphomas, not otherwise specified, and emerging entities.Virchows Arch2023
36635392Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.Leukemia2023
36633689Correction to: Chronic lymphocytic leukaemia/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation.Virchows Arch2023
36566271Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.Leukemia2023
36454275Chronic lymphocytic leukaemia/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation.Virchows Arch2023
36355424MYC and TP53 Alterations but Not MAPK Pathway Mutations Are Common Oncogenic Mechanisms in Follicular Dendritic Cell Sarcomas.Arch Pathol Lab Med2023
34448823The molecular hallmarks of primary and secondary vitreoretinal lymphoma.Blood Adv2022
35443168Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma.Cell Rep2022
35611996Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia.Hematol Oncol2022
35504971Publisher Correction: Signatures of TOP1 transcription-associated mutagenesis in cancer and germline.Nature2022
35672297ATM germline variants in a young adult with chronic lymphocytic leukemia: 8â¿¿years of genomic evolution.Blood Cancer J2022
35609565A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile.Blood Adv2022
35726449A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort.Am J Hematol2022
35850118NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphoma.Hematol Oncol2022
36480778Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care.JCO Precis Oncol2022
36470887Correction: ATM germline variants in a young adult with chronic lymphocytic leukemia: 8 years of genomic evolution.Blood Cancer J2022
36497332Copy Number Alteration and Mutational Profile of High-Grade B-Cell Lymphoma with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> Rearrangements, Diffuse Large B-Cell Lymphoma with <i>MYC</i>-Rearrangement, and Diffuse Large B-Cell Lymphoma with <i>MYC</i>-Cluster Amplification.Cancers (Basel)2022
36001803Genomic profiling for clinical decision making in lymphoid neoplasms.Blood2022
36000950Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma.Pediatr Blood Cancer2022
35927489Molecular map of chronic lymphocytic leukemia and its impact on outcome.Nat Genet2022
36030304Response to "The WHO classification of haematolymphoid tumours" (Editorial).Leukemia2022
35953718Detection of early seeding of Richter transformation in chronic lymphocytic leukemia.Nat Med2022
35885481Cell-Free DNA for Genomic Analysis in Primary Mediastinal Large B-Cell Lymphoma.Diagnostics (Basel)2022
35288589PanCancer analysis of somatic mutations in repetitive regions reveals recurrent mutations in snRNA U2.NPJ Genom Med2022
  • 1 - 50 of 757

Recommended Authors

Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 3
University of British Columbia
Career Start Year 2012
Number of shared co-authors 12
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 0
University of Washington
Career Start Year 2010
Number of shared co-authors 7
Children's Hospital of Los Angeles
Career Start Year 2008
Number of shared co-authors 7
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 2
Intermountain Medical Center
Career Start Year 2007
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 5
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 4
Intermountain Medical Center
Career Start Year 2001
Number of shared co-authors 4
KTH - Royal Institute of Technology
Career Start Year 2000
Number of shared co-authors 0
Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 3
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 4
Institute of Pathology, Paracelsus Medical University
Career Start Year 2000
Number of shared co-authors 1
Seoul St. Mary's Hospital, The Catholic University of Korea
Career Start Year 1999
Number of shared co-authors 0
Institute for Cancer Genetics, Columbia University
Career Start Year 1999
Number of shared co-authors 4
Tuen Mun Hospital
Career Start Year 1999
Number of shared co-authors 1
Rutgers Robert Wood Johnson Medical School
Career Start Year 1998
Number of shared co-authors 8
Merck & Co.
Career Start Year 1998
Number of shared co-authors 13
School of Clinical Medicine, University of Hong Kong
Career Start Year 1997
Number of shared co-authors 3
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 10
University of Paris
Career Start Year 1993
Number of shared co-authors 6
Johns Hopkins University School of Medicine
Career Start Year 1992
Number of shared co-authors 5
Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield
Career Start Year 1991
Number of shared co-authors 1
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 7
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1982
Number of shared co-authors 3
National Cancer Institute, National Institutes of Health
Career Start Year 1981
Number of shared co-authors 12
University Hospital Essen, University of Duisburg-Essen
Career Start Year 1979
Number of shared co-authors 3
Lehigh Valley Hospital
Career Start Year 1977
Number of shared co-authors 0
Sapienza University.
Career Start Year 1968
Number of shared co-authors 16

Collaborators

Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 105
National Cancer Institute, National Institutes of Health
Co-authored papers 78
University of Oviedo
Co-authored papers 44
Instituto Universitario de Oncologia, Universidad de Oviedo
Co-authored papers 41
Co-authored papers 29
Instituto Universitario de Oncologia, Universidad de Oviedo
Co-authored papers 16
National Cancer Institute, National Institutes of Health
Co-authored papers 14
University of British Columbia
Co-authored papers 13
Universitat de Barcelona (UB)
Co-authored papers 12
Human Phenome Institute and Shanghai Cancer Center, Fudan University
Co-authored papers 11
Center for Cancer Research, National Cancer Institute
Co-authored papers 11
Spain Universitat de Barcelona (UB)
Co-authored papers 10
Institucio Catalana de Recerca i Estudis Avancats (ICREA)
Co-authored papers 10
Barcelona Institute of Science and Technology (BIST)
Co-authored papers 9
Uppsala University
Co-authored papers 8
Instituto Universitario de Oncologia (IUOPA), Universidad de Oviedo
Co-authored papers 7
Sidra Medical Center
Co-authored papers 7
Josep Carreras Leukaemia Research Institute (IJC)
Co-authored papers 7
Wellcome Sanger Institute
Co-authored papers 7
Weizmann Institute of Science
Co-authored papers 6
National Cancer Institute, National Institutes of Health
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
National Cancer Institute
Co-authored papers 6
Co-authored papers 5
European Bioinformatics Institute
Co-authored papers 5
Barcelona Institute of Science and Technology
Co-authored papers 5
Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital
Co-authored papers 5
National Center for Advancing Translational Sciences
Co-authored papers 5
Universitat Autonoma de Barcelona
Co-authored papers 5